Comparing SARS-CoV-1 & -2

By Grant M. Gallagher

Adam Brufsky, MD, explains the insights years of research into SARS-CoV-1 may hold for SARS-CoV-2.

Adam Brufsky, MD, explains the insights years of research into SARS-CoV-1 may hold for SARS-CoV-2.

Related Videos
View All
Related Content

As US COVID-19 Vaccine Policy Pivots, CDC Publishes Prevention Measures for Immunocompromised

January 29th 2023

How Do We Transition Patients on Heavy Antibiotics to Outpatient?

December 20th 2022

The Top 5 COVID-19 Stories This Week

January 27th 2023

COVID-19 Pandemic Drove Carbapenem Resistance in Gram-Negative Infections

December 14th 2022

Looking to Safeguard Blood Supply, FDA Proposes Risk Assessment for Blood Donations

January 27th 2023

FDA Withdraws EUA for Evusheld

January 27th 2023

As US COVID-19 Vaccine Policy Pivots, CDC Publishes Prevention Measures for Immunocompromised

January 29th 2023

How Do We Transition Patients on Heavy Antibiotics to Outpatient?

December 20th 2022

The Top 5 COVID-19 Stories This Week

January 27th 2023

COVID-19 Pandemic Drove Carbapenem Resistance in Gram-Negative Infections

December 14th 2022

Looking to Safeguard Blood Supply, FDA Proposes Risk Assessment for Blood Donations

January 27th 2023

FDA Withdraws EUA for Evusheld

January 27th 2023

As US COVID-19 Vaccine Policy Pivots, CDC Publishes Prevention Measures for Immunocompromised

January 29th 2023

How Do We Transition Patients on Heavy Antibiotics to Outpatient?

December 20th 2022

The Top 5 COVID-19 Stories This Week

January 27th 2023

COVID-19 Pandemic Drove Carbapenem Resistance in Gram-Negative Infections

December 14th 2022

Looking to Safeguard Blood Supply, FDA Proposes Risk Assessment for Blood Donations

January 27th 2023

FDA Withdraws EUA for Evusheld

January 27th 2023
About Us
Advertise
Editorial
Contact Us
Do Not Sell My Information
Privacy
Terms & Conditions
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.